For children and teens these days, going back to school doesn鈥檛 only mean new, color-coded notebooks and freshly sharpened pencils. It also means increased academic pressures, heightened social anxiety and less free time as extracurricular activities fill up the calendar.
High-risk pregnancy specialists from Cedars-Sinai will share their research findings at the Society for Maternal-Fetal Medicine 2024 Pregnancy Meeting, Feb.10-14, in National Harbor, Maryland.
Throughout the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Annual Meeting Sept. 30-Oct. 4, 2023, in Nashville, Cedars-Sinai experts will be available to discuss the latest research, innovations and treatment options.
During Breast Cancer Awareness Month, Cedars-Sinai Cancer experts are available to discuss an uptick in breast cancer among younger patients and the innovative ways the academic medical center is treating breast cancer in diverse Southern California communities and beyond.
In 1998, scientists reported being able to derive cells from human embryos that could develop into almost any cell in the body. In 2007, the field took a huge leap when scientists discovered they could reprogram human adult skin cells to act like these embryonic stem cells.
Throughout the COVID-19 pandemic, more than 3,200 Cedars-Sinai Medical Center nurses put on their protective gear and kept on going鈥攑roviding the highest-quality patient care, conducting innovative research and creating new ways for patients to conveniently access Cedars-Sinai experts.
Throughout the European Society of Cardiology (ESC) Congress August 25-28, 2023, in Amsterdam, experts from the Smidt Heart Institute at Cedars-Sinai will be available to discuss advances and innovations in cardiology, including some of the most recent and promising breakthroughs in research.
En julio, sali贸 al mercado el primer an谩lisis de sangre directo al consumidor dise帽ado para evaluar el riesgo de un usuario de desarrollar la enfermedad de Alzheimer.
In July, the first direct-to-consumer blood test designed to assess a user鈥檚 risk for developing Alzheimer鈥檚 disease hit the market.
The temperature feels like summer is still in full swing, yet this week, thousands of Los Angeles schoolchildren headed back to the classroom.
El comienzo del a帽o escolar puede ser dif铆cil para muchos ni帽os. Para algunos, la lucha puede durar solo unos d铆as. Para otros, sin embargo, una transici贸n dif铆cil de regreso a la escuela puede ser un signo de una condici贸n de comportamiento o de desarrollo no detectada que requiere atenci贸n m茅dica.
The start of the school year can be tough for many children. For some, the struggle might last just a few days. For others, however, a difficult transition back to school might be a sign of an undetected behavioral or developmental condition that requires medical attention.
Climate change has supersized summer heat this year, with Southern California expected to again reach more than 100 degrees mid-month. Along with the rise in outdoor temperatures, physicians are seeing an increase in heat-related illnesses following weeks of unrelenting hot weather.
Hyung L. Kim, MD, a leading urologic oncologist, skilled surgeon and accomplished researcher frequently funded by the National Institutes of Health, was recently selected to be the inaugural chair of the Department of Urology at Cedars-Sinai.
Record rain this winter wreaked havoc on Los Angeles area hiking trails, damaging roads and dumping snow at lower elevations than normal. As the weather heats up, and the last of the snow melts, day hikers should plan ahead to avoid on-trail hazards caused by the unusually heavy rainy season.
Cedars-Sinai patient care teams are preparing to offer lecanemab, a new Alzheimer鈥檚 disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.
Experts from Cedars-Sinai, BlackDoctors.org, the California Black Women鈥檚 Health Project and the Morehouse School of Medicine participated in a recent discussion that addressed the high rate of pregnancy-related deaths among Black mothers.
Physicians at Cedars-Sinai Cancer are using a unique chemotherapy delivery system that offers hope to colorectal cancer patients whose disease has spread and who now have inoperable liver tumors. Cedars-Sinai is one of the few centers in the area to offer the therapy, called hepatic artery infusion (HAI) pump chemotherapy.
Cedars-Sinai investigators studying the effects of space on stem cells will present their work at the International Society for Stem Cell Research (ISSCR) Annual Meeting June 14-17 in Boston, and are available for interviews throughout the conference.
Cedars-Sinai endocrinologists will share their latest medical research and clinical care improvements at ENDO 2023, the Endocrine Society鈥檚 annual meeting in Chicago, June 15-18.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
